FI964468A - adenosine - Google Patents

adenosine Download PDF

Info

Publication number
FI964468A
FI964468A FI964468A FI964468A FI964468A FI 964468 A FI964468 A FI 964468A FI 964468 A FI964468 A FI 964468A FI 964468 A FI964468 A FI 964468A FI 964468 A FI964468 A FI 964468A
Authority
FI
Finland
Prior art keywords
adenosine
Prior art date
Application number
FI964468A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI964468A0 (en
Inventor
Fulvio Gadient
Bonnie L K Mangold
John R Fozard
Mahavir Prashad
Prasad K Kapa
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409324A external-priority patent/GB9409324D0/en
Priority claimed from GB9416693A external-priority patent/GB9416693D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of FI964468A0 publication Critical patent/FI964468A0/en
Publication of FI964468A publication Critical patent/FI964468A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI964468A 1994-05-10 1996-11-06 adenosine FI964468A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9409324A GB9409324D0 (en) 1994-05-10 1994-05-10 New organic compounds, their preparation and use
US24991494A 1994-05-26 1994-05-26
GB9416693A GB9416693D0 (en) 1994-08-18 1994-08-18 Improvements in or relating to organic compounds
PCT/US1995/005802 WO1995030683A1 (en) 1994-05-10 1995-05-09 Adenosine derivatives

Publications (2)

Publication Number Publication Date
FI964468A0 FI964468A0 (en) 1996-11-06
FI964468A true FI964468A (en) 1996-11-06

Family

ID=27267177

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964468A FI964468A (en) 1994-05-10 1996-11-06 adenosine

Country Status (13)

Country Link
EP (1) EP0759925A1 (en)
JP (1) JPH09512823A (en)
CN (1) CN1147815A (en)
AU (1) AU2546195A (en)
BR (1) BR9507683A (en)
CA (1) CA2186847A1 (en)
CZ (1) CZ327896A3 (en)
FI (1) FI964468A (en)
HU (1) HUT75338A (en)
NO (1) NO964735L (en)
PL (1) PL316985A1 (en)
SK (1) SK146096A3 (en)
WO (1) WO1995030683A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
GB0228723D0 (en) 2002-12-09 2003-01-15 Cambridge Biotechnology Ltd Treatment of pain
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
WO2007107598A1 (en) 2006-03-21 2007-09-27 Heinrich-Heine-Universität Düsseldorf Phosphorylated a2a receptor agonists
CN108822174A (en) * 2018-08-29 2018-11-16 上海兆维科技发展有限公司 2 '-EOE- guanosine of novel nucleoside modifier and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729994D0 (en) * 1987-12-23 1988-02-03 Glaxo Group Ltd Chemical compounds
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
US5017578A (en) * 1989-06-09 1991-05-21 Hoechst-Roussel Pharmaceuticals Inc. N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents
HUT61567A (en) * 1990-12-07 1993-01-28 Sandoz Ag Process for producing new pharmaceutical compositions comprising 2'-o-alkyladenosine derivatives and for producing 6-cyclohexyl-2'-o-methyladenosinehydrate
DK62692D0 (en) * 1992-05-14 1992-05-14 Novo Nordisk As

Also Published As

Publication number Publication date
HUT75338A (en) 1997-05-28
JPH09512823A (en) 1997-12-22
CZ327896A3 (en) 1997-03-12
NO964735L (en) 1997-01-10
NO964735D0 (en) 1996-11-08
PL316985A1 (en) 1997-03-03
FI964468A0 (en) 1996-11-06
WO1995030683A1 (en) 1995-11-16
SK146096A3 (en) 1997-07-09
HU9603105D0 (en) 1997-01-28
AU2546195A (en) 1995-11-29
EP0759925A1 (en) 1997-03-05
CN1147815A (en) 1997-04-16
BR9507683A (en) 1997-09-23
CA2186847A1 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
DE69527283T2 (en) GASTURBINENGENERATORSET
ATA166795A (en) BIS-RESORCINYLTRIAZINE
ATA147195A (en) ALKOXYPHENYL-SUBSTITUTED BISBENZOYLPHOSPHINOXIDE
ATA163695A (en) 2-HYDROXYPHENYLTRIAZINE
ATA108995A (en) DIFFERENZDRUCKAKKUMULATOR
FI940328A0 (en) Baeranordning
FI964468A0 (en) adenosine
ATA11894A (en) STAUFÖRDERBAHN
SE9402608D0 (en) Cross Water-ski
BR1100457A (en) Aroil derivatives - piperidine
FI1381U1 (en) Baerrem Foer dryckskorger
ATE197372T1 (en) PRE-DOUGH
SE9403065L (en) Retaining
SE9402881D0 (en) Retaining
KR960019939U (en) Filed
BR7400170U (en) Mouráo
BR7402083U (en) Shower-bucket
BR7400030U (en) Numeralfa
BR7400053U (en) T-compact
BR7400062U (en) Dish-tray
ATA127394A (en) HOLOGRAFIC NEUROCHIP
BR7400635U (en) Entopstop
BR7400683U (en) Odontoportable
BR7400865U (en) Multi-finish
BR7400879U (en) Boxboy

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed